Professor John Armstrong is a Board Member and ex-chairman of the Irish Cancer Society. Professor Armstrong was trained at Memorial Sloan-Kettering Cancer Center, where he performed his residency and was Chief resident, attending for five years. He directed the lung cancer radiation research programme at Memorial Sloan-Kettering Cancer Center, and co-authored the chapter on non-small cell lung cancer chapter in 4th edition of DeVita, Hellman, and Rosenberg, Cancer: Principles and Practice of Oncology, Lippincott.
He is currently the Director of Research at St. Luke’s Hospital, Dublin. Professor Armstrong is the Principal Investigator for several clinical trials in the Irish Clinical Oncology Research Group.
Professor Armstrong has published numerous articles and has lectured extensively in the field of radiation oncology. He has been instrumental in the rollout of new procedures involving high-tech radiation therapy procedures such as Intensity Modulated Radiation Therapy, and stereotactic radiosurgery.
"Novartis are delighted to continue to support the Future Health Summit. The event is always high quality from its organisation to its speakers, and is a must attend event for anyone with an interest in improving healthcare and outcomes for patients"Ian Addie, Patient Access Head, Novartis Ireland Ltd
"‘Irish Heart would like to extend our thanks for having our mobile health unit attend the Future Health Summit. The mobile health unit was extremely well received and there was over 130 blood pressure checks taken over the two days,. The event was fantastic."Emma Carter ,Mobile Health Unit Manager ,Irish Heart
"‘I have spoken at and attended this event for the last six years and in a short space of time the Future Health Summit has become an annual meeting place for progressive healthcare leaders who want to drive change and improve healthcare delivery. "Mr. Bill Maher, Chief Executive, Bon Secours Health System
"“This Conference is another one of Ireland’s global contributions. The Future Health Summit is required attendance for all who wish to engage in a stimulating interchange on the future of healthcare – globally and domestically""Michael Dowling , Chief Executive Officer of Northwell Health